Stockreport

Bovie Medical files 510(k) submission for new indication of J-Plasma for use in dermal resurfacing procedures [Seeking Alpha]

BOVIE MEDICAL  (BVX) 
NASDAQ:AMEX Investor Relations: boviemedical.com/investor_relations
PDF Bovie Medical (NYSEMKT: BVX )  announces a Premarket Notification 510(NYSE: K ) submission to the FDA for a new indication to market and sell J-Plasma/Renuvion [Read more]